Return to search

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Background: The knowledge of factors influencing disease progression in patients with
established coronary heart disease (CHD) is still relatively limited. One potential pathway is
related to peroxisome proliferator–activated receptor gamma coactivator-1 alpha
(PPARGC1A), a transcription factor linked to energy metabolism which may play a role
in the heart function. Thus, its associations with subsequent CHD events remain unclear.
We aimed to investigate the effect of three different SNPs in the PPARGC1A gene on the
risk of subsequent CHD in a population with established CHD.
Methods: We employed an individual-level meta-analysis using 23 studies from the
GENetIcs of sUbSequent Coronary Heart Disease (GENIUS-CHD) consortium, which
included participants (n = 80,900) with either acute coronary syndrome, stable CHD, or a
mixture of both at baseline. Three variants in the PPARGC1A gene (rs8192678, G482S;
rs7672915, intron 2; and rs3755863, T528T) were tested for their associations with
subsequent events during the follow-up using a Cox proportional hazards model adjusted
for age and sex. The primary outcome was subsequent CHD death or myocardial
infarction (CHD death/myocardial infarction). Stratified analyses of the participant or
study characteristics as well as additional analyses for secondary outcomes of specific
cardiovascular disease diagnoses and all-cause death were also performed.
Results: Meta-analysis revealed no significant association between any of the three
variants in the PPARGC1A gene and the primary outcome of CHD death/myocardial
infarction among those with established CHD at baseline: rs8192678, hazard ratio (HR):
1.01, 95% confidence interval (CI) 0.98–1.05 and rs7672915, HR: 0.97, 95% CI
0.94–1.00; rs3755863, HR: 1.02, 95% CI 0.99–1.06. Similarly, no significant
associations were observed for any of the secondary outcomes. The results from
stratified analyses showed null results, except for significant inverse associations
between rs7672915 (intron 2) and the primary outcome among 1) individuals aged
≥65, 2) individuals with renal impairment, and 3) antiplatelet users.
Conclusion: We found no clear associations between polymorphisms in the PPARGC1A
gene and subsequent CHD events in patients with established CHD at baseline.

Identiferoai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:87694
Date26 October 2023
CreatorsSchillemans, Tessa, Tragante, Vinicius, Maitusong, Buamina, Gigante, Bruna, Cresci, Sharon, Laguzzi, Federica, Vikström, Max, Richards, Mark, Pilbrow, Anna, Cameron, Vicky, Foco, Luisa, Doughty, Robert N., Kuukasjärvi, Pekka, Allayee, Hooman, Hartiala, Jaana A., Tang, W.H. Wilson, Lyytikäinen, Leo-Pekka, Nikus, Kjell, Laurikka, Jari O., Srinivasan, Sundararajan, Mordi, Ify R., Trompet, Stella, Kraaijeveld, Adriaan, van Setten, Jessica, Gijsberts, Crystel M., Maitland-van der Zee, Anke H., Saely, Christoph H., Gong, Yan, Johnson, Julie A., Cooper-DeHoff, Rhonda M., Pepine, Carl J., Casu, Gavino, Leiherer, Andreas, Drexel, Heinz, Horne, Benjamin D., van der Laan, Sander W., Marziliano, Nicola, Hazen, Stanley L., Sinisalo, Juha, Kähönen, Mika, Lehtimäki, Terho, Lang, Chim C., Burkhardt, Ralph, Scholz, Markus, Jukema, J. Wouter, Eriksson, Niclas, Akerblom, Axel, James, Stefan, Held, Claes, Hagström, Emil, Spertus, John A., Algra, Ale, de Faire, Ulf, Akesson, Agneta, Asselbergs, Folkert W., Patel, Riyaz S., Leander, Karin
PublisherFrontiers Media S.A.
Source SetsHochschulschriftenserver (HSSS) der SLUB Dresden
LanguageEnglish
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text
Rightsinfo:eu-repo/semantics/openAccess
Relation909870

Page generated in 0.0022 seconds